Literature DB >> 10489260

Higher seizure susceptibility and enhanced tyrosine phosphorylation of N-methyl-D-aspartate receptor subunit 2B in fyn transgenic mice.

N Kojima1, H Ishibashi, K Obata, E R Kandel.   

Abstract

Earlier work has suggested that Fyn tyrosine kinase plays an important role in synaptic plasticity. To understand the downstream targets of Fyn signaling cascade in neurons, we generated transgenic mice expressing either a constitutively activated form of Fyn or native Fyn in neurons of the forebrain. Transgenic mice expressing mutant Fyn exhibited higher seizure activity and were prone to sudden death. Mice overexpressing native Fyn did not show such an obvious epileptic phenotype, but they exhibited accelerated kindling in response to once-daily stimulation of the amygdala. Tyrosine phosphorylation of at least three proteins was enhanced in the forebrains of both native and mutant fyn transgenic mice; tyrosine phosphorylation of these three proteins was reduced in fyn knockout mice, suggesting that they are substrates of Fyn. One of these proteins was identified as the subunit 2B (NR2B) of the N-methyl-D-aspartate (NMDA) receptor. Administration of MK-801, a noncompetitive NMDA receptor antagonist, retarded kindling in mice overexpressing native Fyn, as well as wild-type mice, suggests that the accelerated kindling in mice overexpressing Fyn is also mediated by the NMDA receptor activity. Our results thus suggest that tyrosine phosphorylation by Fyn might be involved in regulation of the susceptibility of kindling, one form of the NMDA receptor-mediated neuronal plasticity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10489260      PMCID: PMC311255     

Source DB:  PubMed          Journal:  Learn Mem        ISSN: 1072-0502            Impact factor:   2.460


  53 in total

1.  Competitive binding of alpha-actinin and calmodulin to the NMDA receptor.

Authors:  M Wyszynski; J Lin; A Rao; E Nigh; A H Beggs; A M Craig; M Sheng
Journal:  Nature       Date:  1997-01-30       Impact factor: 49.962

2.  NMDA channel regulation by channel-associated protein tyrosine kinase Src.

Authors:  X M Yu; R Askalan; G J Keil; M W Salter
Journal:  Science       Date:  1997-01-31       Impact factor: 47.728

3.  Normal cerebellar development but susceptibility to seizures in mice lacking G protein-coupled, inwardly rectifying K+ channel GIRK2.

Authors:  S Signorini; Y J Liao; S A Duncan; L Y Jan; M Stoffel
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-04       Impact factor: 11.205

4.  Modification of seizure activity by electrical stimulation. II. Motor seizure.

Authors:  R J Racine
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1972-03

5.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

6.  The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures.

Authors:  M E Gilbert
Journal:  Brain Res       Date:  1988-10-25       Impact factor: 3.252

7.  Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy.

Authors:  K Sato; K Morimoto; M Okamoto
Journal:  Brain Res       Date:  1988-10-25       Impact factor: 3.252

8.  The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.

Authors:  M D Tricklebank; L Singh; R J Oles; C Preston; S D Iversen
Journal:  Eur J Pharmacol       Date:  1989-08-11       Impact factor: 4.432

9.  Expression of a novel form of the fyn proto-oncogene in hematopoietic cells.

Authors:  M P Cooke; R M Perlmutter
Journal:  New Biol       Date:  1989-10

10.  The N-methyl-D-aspartate antagonists aminophosphonovalerate and carboxypiperazinephosphonate retard the development and expression of kindled seizures.

Authors:  K H Holmes; D K Bilkey; R Laverty; G V Goddard
Journal:  Brain Res       Date:  1990-01-08       Impact factor: 3.252

View more
  29 in total

Review 1.  Fyn in Neurodevelopment and Ischemic Brain Injury.

Authors:  Renatta Knox; Xiangning Jiang
Journal:  Dev Neurosci       Date:  2015-02-17       Impact factor: 2.984

Review 2.  The Role of Intracellular Sodium in the Regulation of NMDA-Receptor-Mediated Channel Activity and Toxicity.

Authors:  Xian-Min Yu
Journal:  Mol Neurobiol       Date:  2006-02       Impact factor: 5.590

Review 3.  Beta-amyloid modulation of synaptic transmission and plasticity.

Authors:  Deepa V Venkitaramani; Jeannie Chin; William J Netzer; Gunnar K Gouras; Sylvain Lesne; Roberto Malinow; Paul J Lombroso
Journal:  J Neurosci       Date:  2007-10-31       Impact factor: 6.167

Review 4.  Protein kinases and addiction.

Authors:  Anna M Lee; Robert O Messing
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 5.  Src family kinases in chronic kidney disease.

Authors:  Jun Wang; Shougang Zhuang
Journal:  Am J Physiol Renal Physiol       Date:  2017-06-14

6.  Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease.

Authors:  Erik D Roberson; Brian Halabisky; Jong W Yoo; Jinghua Yao; Jeannie Chin; Fengrong Yan; Tiffany Wu; Patricia Hamto; Nino Devidze; Gui-Qiu Yu; Jorge J Palop; Jeffrey L Noebels; Lennart Mucke
Journal:  J Neurosci       Date:  2011-01-12       Impact factor: 6.167

7.  IGF-1-Involved Negative Feedback of NR2B NMDA Subunits Protects Cultured Hippocampal Neurons Against NMDA-Induced Excitotoxicity.

Authors:  Yun Li; Wei Sun; Song Han; Jianing Li; Shu Ding; Wei Wang; Yanling Yin
Journal:  Mol Neurobiol       Date:  2016-01-13       Impact factor: 5.590

8.  AlphaScreen HTS and live-cell bioluminescence resonance energy transfer (BRET) assays for identification of Tau-Fyn SH3 interaction inhibitors for Alzheimer disease.

Authors:  J Nicholas Cochran; Pauleatha V Diggs; N Miranda Nebane; Lynn Rasmussen; E Lucile White; Robert Bostwick; Joseph A Maddry; Mark J Suto; Erik D Roberson
Journal:  J Biomol Screen       Date:  2014-08-25

9.  The Kinase Fyn As a Novel Intermediate in L-DOPA-Induced Dyskinesia in Parkinson's Disease.

Authors:  Sara Sanz-Blasco; Melina P Bordone; Ana Damianich; Gimena Gomez; M Alejandra Bernardi; Luciana Isaja; Irene R Taravini; Diane P Hanger; M Elena Avale; Oscar S Gershanik; Juan E Ferrario
Journal:  Mol Neurobiol       Date:  2017-08-24       Impact factor: 5.590

Review 10.  Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.

Authors:  Ravi Rajmohan; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.